Biofil Chemicals and Pharmaceuticals Limited (NSE:BIOFILCHEM)
India · Delayed Price · Currency is INR 32.13
-0.16 (-0.50%)
Sep 24, 2026, 3:29 PM IST
NSE:BIOFILCHEM Market Cap
NSE:BIOFILCHEM has a market cap or net worth of 524.99 million as of September 23, 2026. Its market cap has decreased by -25.46% in one year.
Market Cap
524.99M
Enterprise Value
521.93M
Revenue
346.26M
Ranking
n/a
PE Ratio
108.45
Stock Price
32.13
ChartMarket Cap Chart
Since December 31, 2001, NSE:BIOFILCHEM's market cap has increased from 34.17M to 524.99M, an increase of 1,436.19%. That is a compound annual growth rate of 11.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 524.99M | -5.48% |
| Dec 31, 2025 | 555.42M | -40.49% |
| Dec 31, 2024 | 933.30M | 6.14% |
| Dec 29, 2023 | 879.27M | -2.21% |
| Dec 30, 2022 | 899.13M | -11.24% |
| Dec 31, 2021 | 1.01B | -63.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bafna Pharmaceuticals | 7.81B |
| Amanta Healthcare | 7.20B |
| Valiant Laboratories | 6.87B |
| Nectar Lifesciences | 2.10B |
| Brooks Laboratories | 1.74B |
| Par Drugs and Chemicals | 1.70B |
| Alpa Laboratories | 1.29B |
| Balaxi Pharmaceuticals | 1.28B |